Roles of JUMONJI in mouse embryonic development

Developmental Dynamics

Volumn 232, Issue 1, 2005, Pages 21-32

  Jung, Jooyoung ^a   Mysliwiec, Matthew R ^a   Lee, Youngsook ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

ARID transcription factor family; Cardiac development; Gene trap technology; Jumonji; Transcription factors

Indexed keywords

ARID TRANSCRIPTION FACTOR; BETA GALACTOSIDASE; COMPLEMENTARY RNA; DNA; JUMONJI PROTEIN; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

AT RICH SEQUENCE; BIRTH DEFECT; CARDIOVASCULAR SYSTEM; CELL CYCLE; CONGENITAL HEART MALFORMATION; DEVELOPMENTAL GENETICS; DNA BINDING; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TECHNOLOGY; GENE TRAP TECHNOLOGY; GENETIC TRANSCRIPTION; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; JUMONJI GENE; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; RNA PROBE; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOVASCULAR SYSTEM; CELL CYCLE; CELL MOVEMENT; CELL NUCLEUS; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROZYGOTE; HOMOZYGOTE; LIVER; MICE; MODELS, ANATOMIC; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURAL CREST; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 11244302905     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20204     Document Type: Review

References (105)

1. Ahmad W, Faiyaz ul Haque M, Brancolini V, Tsou HC, ul Haque S, Lam H, Aita VM, Owen J, deBlaquiere M, Frank J, Cserhalmi-Friedman PB, Leask A, McGrath JA, Peacocke M, Ahmad M, Ott J, Christiano AM. 1998. Alopecia universalis associated with a mutation in the human hairless gene. Science 279:720-724.
2. Anzai H, Kamiya A, Shirato H, Takeuchi T, Miyajima A. 2003. Impaired differentiation of fetal hepatocytes in homozygous jumonji mice. Mech Dev 120:791-800.
3. Ayoub N, Noma K, Isaac S, Kahan T, Grewal SI, Cohen A. 2003. A novel jmjC domain protein modulates heterochromatization in fission yeast. Mol Cell Biol 23:4356-4370.
4. Baker RK, Haendel MA, Swanson BJ, Shambaugh JC, Micales BK, Lyons GE. 1997. In vitro preselection of gene-trapped embryonic stem cell clones for characterizing novel developmentally regulated genes in the mouse. Dev Biol 185:201-214.
5. Balciunas D, Ronne H. 2000. Evidence of domain swapping within the jumonji family of transcription factors. Trends Biochem Sci 25:274-276.
6. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. 1994. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 8:2964-2973.
7. Bartram U, Molin DG, Wisse LJ, Mohamad A, Sanford LP, Doetschman T, Speer CP, Poelmann RE, Gittenberger-de Groot AC. 2001. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 103:2745-2752.
8. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE. 1997. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15:30-35.
9. Belaguli NS, Sepulveda JL, Nigam V, Charron F, Nemer M, Schwartz RJ. 2000. Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol Cell Biol 20:7550-7558.
10. Berge-Lefranc JL, Jay P, Massacrier A, Cau P, Mattei MG, Bauer S, Marsollier C, Berta P, Fontes M. 1996. Characterization of the human jumonji gene. Hum Mol Genet 5:1637-1641.
11. Brewer S, Jiang X, Donaldson S, Williams T, Sucov HM. 2002. Requirement for AP-2alpha in cardiac outflow tract morphogenesis. Mech Dev 110:139-149.
12. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG, Seidman CE. 1999. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 211:100-108.
13. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709-721.
14. Campione M, Ros MA, Icardo JM, Piedra E, Christoffels VM, Schweickert A, Blum M, Franco D, Moorman AF. 2001. Pitx2 expression defines a left cardiac lineage of cells: evidence for atrial and ventricular molecular isomerism in the iv/iv mice. Dev Biol 231:252-264.
15. Chen CY, Schwartz RJ. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol Cell Biol 16:6372-6384.
16. Chen J, Kubalak SW, Chien KR. 1998. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 125:1943-1949.
17. Chen J, Kitchen CM, Streb JW, Miano JM. 2002a. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34:1345-1356.
18. Chen TH, Chang TC, Kang JO, Choudhary B, Makita T, Tran CM, Burch JB, Eid H, Sucov HM. 2002b. Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev Biol 250:198-207.
19. Chen Z, Friedrich GA, Soriano P. 1994. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev 8:2293-2301.
20. Clissold PM, Ponting CP. 2001. JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci 26:7-9.
21. Cripps RM, Olson EN. 2002. Control of cardiac development by an evolutionarily conserved transcriptional network. Dev Biol 246:14-28.
22. Czubryt MP, McAnally J, Fishman GI, Olson EN. 2003. Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci U S A 100:1711-1716.
23. Defeo-Jones D, Huang PS, Jones RE, Haskell KM, Vuocolo GA, Hanobik MG, Huber HE, Oliff A. 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352:251-254.
24. Dudley AT, Lyons KM, Robertson EJ. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807.
25. Durocher D, Chen CY, Ardati A, Schwartz RJ, Nemer M. 1996. The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol 16:4648-4655.
26. Durocher D, Charron F, Warren R, Schwartz RJ, Nemer M. 1997. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16:5687-5696.
27. Eisenberg LM, Markwald RR. 1995. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77:1-6.
28. Fattaey AR, Helin K, Dembski MS, Dyson N, Harlow E, Vuocolo GA, Hanobik MG, Haskell KM, Oliff A, Defeo-Jones D, Jones RE. 1993. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 8:3149-3156.
29. Franco D, Campione M. 2003. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc Med 13:157-163.
30. Friedrich G, Soriano P. 1991. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5:1513-1523.
31. Ganga M, Espinoza HM, Cox CJ, Morton L, Hjalt TA, Lee Y, Amendt BA. 2003. PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5. J Biol Chem 278:22437-22445.
32. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443-447.
33. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378:390-394.
34. Gittenberger-de Groot AC, Vrancken Peeters MP, Bergwerff M, Mentink MM, Poelmann RE. 2000. Epicardial outgrowth inhibition leads to compensatory mesothelial outflow tract collar and abnormal cardiac septation and coronary formation. Circ Res 87:969-971.
35. Gourdie RG, Mima T, Thompson RP, Mikawa T. 1995. Terminal diversification of the myocyte lineage generates Purkinje fibers of the cardiac conduction system. Development 121:1423-1431.
36. Gregory SL, Kortschak RD, Kalionis B, Saint R. 1996. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol Cell Biol 16:792-799.
37. Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI. 1995. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 9:1-14.
38. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, Tucker PW. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev 9:3067-3082.
39. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, Komuro I. 2001. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 28:276-280.
40. Hogers B, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. 1997. Unilateral vitelline vein ligation alters intra-cardiac blood flow patterns and morphogenesis in the chick embryo. Circ Res 80:473-481.
41. Huang TH, Oka T, Asai T, Okada T, Merrills BW, Gertson PN, Whitson RH, Itakura K. 1996. Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res 24:1695-1701.
42. Iwahara J, Clubb RT. 1999. Solution structure of the DNA binding domain from Dead ringer, a sequence-specific AT-rich interaction domain (ARID). EMBO J 18:6084-6094.
43. Kim TG, Kraus JC, Chen J, Lee Y. 2003. JUMONJI, a critical factor for cardiac development, functions as a transcriptional repressor. J Biol Chem 278:42247-42255.
44. Kitajima K, Kojima M, Nakajima K, Kondo S, Hara T, Miyajima A, Takeuchi T. 1999. Definitive but not primitive hematopoiesis is impaired in jumonji mutant mice. Blood 93:87-95.
45. Kim TG, Chen J, Sadoshima J, Lee Y. 2004. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol Cell Biol, in press.
46. Komuro I, Izumo S. 1993. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A 90:8145-8149.
47. Kortschak RD, Tucker PW, Saint R. 2000. ARID proteins come in from the desert. Trends Biochem Sci 25:294-299.
48. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. 1997. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11:1048-1060.
49. Kim TG, Chen J, Sadoshima J, Lee Y. 2004. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol Cell Biol, in press.
50. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA. 1995. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121:489-503.
51. Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG Jr, Seto E, Branton PE. 1999. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol 19:6632-6641.
52. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA. 1998a. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol Cell Biol 18:7455-7465.
53. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA. 1998b. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669-4679.
54. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C. 1995. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378:394-398.
55. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10:1621-1632.
56. Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S. 1997. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol Cell Biol 17:2745-2755.
57. Lee Y, Shioi T, Kasahara H, Jobe SM, Wiese RJ, Markham BE, Izumo S. 1998. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol 18:3120-3129.
58. Lee Y, Song AJ, Baker R, Micales B, Conway SJ, Lyons GE. 2000. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 86:932-938.
59. Lee Y, Grass JA, Ridolfi TJ. 2001. Jumonji functions as a transcriptional repressor of the cardiac-specific gene. Circulation Suppl 104:II-76.
60. Lin Q, Schwarz J, Bucana C, Olson EN. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
61. Logan M, Pagan-Westphal SM, Smith DM, Paganessi L, Tabin CJ. 1998. The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell 94:307-317.
62. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. 1995. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9:1654-1666.
63. McFadden DG, Olson EN. 2002. Heart development: learning from mistakes. Curr Opin Genet Dev 12:328-335.
64. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P, Mark M. 1994. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120:2749-2771.
65. Mikawa T, Gourdie RG. 1996. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 174:221-232.
66. Mjaatvedt CH, Yamamura H, Wessels A, Ramsdell A, Turner D, Markward RR. 1999. Mechanisms of segmentation, septation, and remodeling of the tubular heart: endocardial cushion fate and cardiac looping. In: Harvey RP, Rosenthal N, editors. Heart development. San Diego: Academic Press. p 159-177.
67. Molkentin JD, Lin Q, Duncan SA, Olson EN. 1997. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11:1061-1072.
68. Moorman AFM, Lamers WH. 1999. Development of the conduction system of the vertebrate heart. Heart development. San Diego: Academic Press. p 195-207.
69. Motoyama J, Kitajima K, Kojima M, Kondo S, Takeuchi T. 1997. Organogenesis of the liver, thymus and spleen is affected in jumonji mutant mice. Mech Dev 66:27-37.
70. Noden DM, Loelmann RE, Gittenber-de Groot AC. 1995. Cell origins and tissue boundaries during outflow tract development. Trends Cardiovasc Med 5:69-75.
71. Ohno T, Nakajima K, Kojima M, Toyoda M, Takeuchi T. 2004. Modifiers of the jumonji mutation downregulate cyclin D1 expression and cardiac cell proliferation. Biochem Biophys Res Commun 317:925-929.
72. Olson EN. 2004. A decade of discoveries in cardiac biology. Nat Med 10:467-474.
73. Olson EN, Schneider MD. 2003. Sizing up the heart: development redux in disease. Genes Dev 17:1937-1956.
74. Olson EN, Srivastava D. 1996. Molecular pathways controlling heart development. Science 272:671-676.
75. Peterson CL, Herskowitz I. 1992. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell 68:573-583.
76. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, Craigen WJ, Wu J, El Said H, Bezold LI, Clunie S, Fernbach S, Bowles NE, Towbin JA. 2003. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 108:2672-2678.
77. Sakata Y, Kamei CN, Nakagami H, Bronson R, Liao JK, Chin MT. 2002. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A 99:16197-16202.
78. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670.
79. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281:108-111.
80. Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, Harris TM, Yamagishi H, Richardson JA, Childs G, Olson EN. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110:725-735.
81. Sibilia M, Wagner EF. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-238.
82. Spicer DB, Rhee J, Cheung WL, Lassar AB. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272:1476-1480.
83. Srivastava D, Cserjesi P, Olson EN. 1995. A subclass of bHLH proteins required for cardiacmorphogenesis. Science 270:1995-1999.
84. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8:1007-1018.
85. Svensson EC, Tufts RL, Polk CE, Leiden JM. 1999. Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes. Proc Natl Acad Sci U S A 96:956-961.
86. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. 1995. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 9:1211-1222.
87. Takeuchi T, Kojima M, Nakajima K, Kondo S. 1999. jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech Dev 86:29-38.
88. Tevosian SG, Deconinck AE, Cantor AB, Rieff HI, Fujiwara Y, Corfas G, Orkin SH. 1999. FOG-2: a novel GATA-family cofactor related to multitype zinc-finger proteins Friend of GATA-1 and U-shaped. Proc Natl Acad Sci U S A 96:950-955.
89. Tevosian SG, Deconinck AE, Tanaka M, Schinke M, Litovsky SH, Izumo S, Fujiwara Y, Orkin SH. 2000. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101:729-739.
90. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M, Susuki-Migishima R, Mogegi Y, Yokoyama M, Takeuchi T. 2003. Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 5:85-97.
91. Tran CM, Sucov HM. 1998. The RXRalpha gene functions in a non-cell-autonomous manner during mouse cardiac morphogenesis. Development 125:1951-1956.
92. Treisman JE, Luk A, Rubin GM, Heberlein U. 1997. eyelid antagonizes wingless signaling during Drosophila development and has homology to the Bright family of DNA-binding proteins. Genes Dev 11:1949-1962.
93. Valentine SA, Chen G, Shandala T, Fernandez J, Mische S, Saint R, Courey AJ. 1998. Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol Cell Biol 18:6584-6594.
94. Vazquez M, Moore L, Kennison JA. 1999. The trithorax group gene osa encodes an ARID-domain protein that genetically interacts with the brahma chromatin-remodeling factor to regulate transcription. Development 126:733-742.
95. Viragh S, Challice CE. 1981. The origin of the epicardium and the embryonic myocardial circulation in the mouse. Anat Rec 201:157-168.
96. Wang GF, Stockdale FE. 1999. Chamber-specific gene expression and regulation during heart development. Heart development. San Diego: Academic Press, p 367-369.
97. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851-862.
98. Whitson RH, Huang T, Itakura K. 1999. The novel Mrf-2 DNA-binding domain recognizes a five-base core sequence through major and minor-groove contacts. Biochem Biophys Res Commun 258:326-331.
99. Wilson-Rawls J, Molkentin JD, Black BL, Olson EN. 1999. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol Cell Biol 19:2853-2862.
100. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML. 1999. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126:3597-3605.
101. Wunsch AM, Little CD, Markwald RR. 1994. Cardiac endothelial heterogeneity defines valvular development as demonstrated by the diverse expression of JB3, an antigen of the endocardial cushion tissue. Dev Biol 165:585-601.
102. Wurst W, Rossant J, Prideaux V, Kownacka M, Joyner A, Hill DP, Guillemot F, Gasca S, Cado D, Auerbach A, et al. 1995. A large-scale gene-trap screen for insertional mutations in developmentally regulated genes in mice. Genetics 139:889-899.
103. Yamagishi H, Yamagishi C, Nakagawa O, Harvey RP, Olson EN, Srivastava D. 2001. The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 239:190-203
104. Yang JT, Rayburn H, Hynes RO. 1995. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121:549-560.
105. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479-488.